Skip to main content
NIH
Posted

PAR-23-229

NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)

Summary

AI-generated

NIH Brain Development Cohorts (NBDC) Biospecimen Access (PAR-23-229)

Research Focus

This Resource Access Award provides investigators access to biospecimens from the Adolescent Brain Cognitive Development (ABCD) Study, the largest longitudinal cohort of U.S. brain development, enrolling nearly 12,000 children ages 9–10 at 21 sites (2016–2018) with 10 years of follow-up data. The ABCD Study collects multimodal neuroimaging, behavioral assessments, and diverse biospecimens—including oral fluids (hormone analysis), blood (genetics, metabolic and hematologic assays), urine and hair (substance use and environmental exposures), and deciduous teeth (environmental toxins)—to examine how childhood experiences (sports, social media, sleep patterns, substance use) interact with biology to shape brain development and health outcomes through adolescence into adulthood. Researchers may access these specimens to conduct meritorious studies aligned with ABCD objectives or that expand knowledge of adolescent health broadly, including investigations of neurocognitive function, physical and mental health, substance use, and environmental exposures.

At a Glance

  • Who can apply: Investigators from any institution proposing non-clinical-trial research consistent with ABCD Study objectives or adolescent health broadly; no clinical trials allowed.
  • Funding & project length: No funds provided through this mechanism; applicants must secure separate NIH funding (e.g., R01/R21 ABCD or drug abuse research programs) and cover sample distribution costs.
  • Award / mechanism: X01 Resource Access Award—access to biospecimens only, not a grant.
  • Key dates: Letter of Intent due 30 days before application deadline; rolling submission cycles (next: February 6, 2025 application due, May 2025 earliest start); expires May 6, 2026.
  • Best fit for: Developmental neuroscience, adolescent psychiatry, substance abuse, environmental health, and pediatric epidemiology researchers studying brain development, behavioral health, and biomarkers in a large, diverse U.S. cohort.

Key Facts

Deadline

Tue, May 5, 2026

Posted

Fri, August 11, 2023

93.399
93.313
93.273
93.279
93.307
93.113
93.242
Grants.gov
Agency

Keywords

adolescent brain development
biospecimen analysis
longitudinal cohort studies
neuroimaging
substance use assessment
pubertal hormones
genetic analysis
behavioral assessment
hematologic assays
DNA analysis
brain structure and function

Research Areas

MeSH
AnatomyA
Nervous SystemA08CellsA11Fluids & SecretionsA12
OrganismsB
EukaryotaB01
DiseasesC
Nervous System DiseasesC10Congenital & Hereditary DiseasesC16Nutritional & Metabolic DiseasesC18Endocrine System DiseasesC19Immune System DiseasesC20
Chemicals & DrugsD
Macromolecular SubstancesD05Hormones & AntagonistsD06Amino Acids, Peptides & ProteinsD12Nucleic Acids & NucleotidesD13Biological FactorsD23
Analytical/Diagnostic/Therapeutic TechniquesE
DiagnosisE01Investigative TechniquesE05
Psychiatry & PsychologyF
Behavior MechanismsF01Psychological PhenomenaF02Mental DisordersF03
Phenomena & ProcessesG
MetabolismG03Cell PhysiologyG04Genetic PhenomenaG05Immune System PhenomenaG12
Anthropology/Education/SociologyI
Social SciencesI01
Health CareN
Health Care ServicesN02Health Care EconomicsN03Health Care Quality & EvaluationN05Environment & Public HealthN06
ANZSRC FoR
Biological Sciences31
Biochemistry & Cell Biology3101Genetics3105
Biomedical & Clinical Sciences32
Immunology3204Medical Biochemistry & Metabolomics3205Medical Microbiology3207Neurosciences3209
Health Sciences42
Epidemiology4202Public Health4206
Mathematical Sciences49
Statistics4905
Psychology52
Biological Psychology5202Clinical & Health Psychology5203

Gotchas (6)

Soft Block
planningprogram clinical trial

Clinical trials are explicitly not allowed for this X01 mechanism. The title and award information both state 'Clinical Trial Not Allowed', which is a hard eligibility constraint that could disqualify

AI

98%

Source Text

Clinical Trial? Not Allowed: Only accepting applications that do not propose clinical trials.

Soft Block
planningbudget amount caps

This is a resource access award (X01) that provides NO FUNDING. Applicants must secure separate funding through other NIH mechanisms (R01, R21, HHEAR, or parent announcements) and submit proof of suff

AI

98%

Source Text

No funds will be provided through this opportunity. Applicants will be responsible for costs associated with conducting the research and sample distribution. Several NIH funding opportunities may be of interest... Applicants will need to submit proof of sufficient funding at the time of application.

Soft Block
writingsubmission pre submission

Mandatory pre-application step: Biospecimen Availability Inquiry must be submitted via NBDC portal at least 4 weeks before deadline; Resource Availability and Impact Report must be included in applica

AI

95%

Source Text

Interested applicants are strongly encouraged to explore available biospecimens and complete a Letter of Intent in the form of a Biospecimen Availability Inquiry via the NBDC portal at least 4 weeks prior to the submission deadline... Applicants must include the Resource Availability and Impact Report as a PDF file labeled Resource Availability and Impact Report in Other Attachments.

Warning
planningaward terms conditions

Recipients must adhere to separate award conditions including signing the NBDC Specimen and Data Use Agreement and ABCD Study data archives' Data Use Certification, and must reference the Research Res

AI

90%

Source Text

Recipients who are granted access to the ABCD biospecimens will be required to adhere to the separate award conditions noted in the ABCD data use agreement, including signing the NBDC Specimen and Data Use Agreement and ABCD Study data archives' Data Use Certification, and referencing the Research Resource ID associated with the ABCD study.

Warning
planningprogram required components

Applicants proposing longitudinal designs using samples from multiple time-points must demonstrate adequate storage capabilities. This is an unusual requirement that could affect feasibility assessmen

AI

85%

Source Text

Applicants may apply for access to samples from multiple time-points if they are proposing a feasible longitudinal design and can demonstrate adequate storage capabilities.

Warning
discoverymeta ambiguity

The NOFO was updated on March 31, 2025 to align with agency priorities, with an explicit instruction to 'carefully reread the full funding opportunity and make any needed adjustments to your applicati

AI

88%

Source Text

This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.

AI-generated content — verify with the issuing agency’s official FOA/NOFO. Not endorsed by HHS.

© 2026 Biostochastics, Seattle WA · Contact · Terms · About